Oncimmune
Contract Research Organisation
- Website
- https://www.oncimmune.com/
- Membership category
- Corporate
1 Park Row, Leeds, LS1 5AB, United Kingdom
Oncimmune at a glance
Oncimmune is a precision medicine company, unlocking the immune system to discover unique autoantibody signatures and biomarkers across many immune-mediated diseases.
About Oncimmune
Oncimmune is a pioneering precision medicine company, specialising in identifying unique autoantibody signatures. Using their novel ImmunoINSIGHTS™ platform, Oncimmune unlocks the B-cell repertoire, to discover and convert autoantibodies into actionable biomarkers across many immune-mediated diseases: from immuno-oncology and infectious diseases to diabetes and autoimmune conditions. The technology has demonstrated its predictive power of immune related adverse events. Coupled with the platform's unique plug-and-play approach, ImmunoINSIGHTS empowers life science organizations to harness autoantibodies for early-stage discovery, MoA validation, patient stratification and companion diagnostics.
With a library spanning 9000+ antigens, validated in human as well as multiple animal and disease models, Oncimmune can extract autoantibodies from various biological samples in very low volume (50 μl). In conjunction with their contract service, the company is actively seeking partners to co-develop new biomarkers and therapies, promising more targeted and effective treatments, ultimately leading to improved patient outcomes.
